Cargando…

Prevalence of molecular markers of sulfadoxine–pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan

BACKGROUND: In Pakistan, artesunate (AS) in combination with sulfadoxine–pyrimethamine (SP) is the recommended treatment for uncomplicated Plasmodium falciparum malaria. Monitoring molecular markers of anti-malarial drug resistance is crucial for early detection and containment of parasite resistanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yaqoob, Adnan, Khattak, Aamer Ali, Nadeem, Muhammad Faisal, Fatima, Huma, Mbambo, Gillian, Ouattara, Amed, Adams, Matthew, Zeeshan, Nadia, Takala-Harrison, Shannon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296135/ https://www.ncbi.nlm.nih.gov/pubmed/30558587 http://dx.doi.org/10.1186/s12936-018-2620-y

Ejemplares similares

Chloroquine-resistant Plasmodium falciparum in Pakistan
por: Khattak, Aamer Ali, et al.
Publicado: (2021)

Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
por: Kavishe, Reginald A., et al.
Publicado: (2016)

Molecular Markers for Sulfadoxine/Pyrimethamine and Chloroquine Resistance in Plasmodium falciparum in Thailand
por: Kuesap, Jiraporn, et al.
Publicado: (2022)

Surveillance of molecular markers of antimalarial drug resistance in Plasmodium falciparum and Plasmodium vivax in Federally Administered Tribal Area (FATA), Pakistan
por: Nadeem, Muhammad Faisal, et al.
Publicado: (2021)

Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan
por: Elamin, Sakina B, et al.
Publicado: (2005)

Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum
por: Brock, Aleisha R., et al.
Publicado: (2017)

Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia
por: Lederman, Edith R, et al.
Publicado: (2006)

Low-grade sulfadoxine–pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola
por: Kaingona-Daniel, Elsa P. S., et al.
Publicado: (2016)

Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi
por: Ravenhall, Matt, et al.
Publicado: (2016)

Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in Africa: a systematic analysis of national trends
por: Amimo, Floriano, et al.
Publicado: (2020)

High efficacy of two artemisinin-based combinations: artesunate + sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen
por: Adeel, Ahmed A., et al.
Publicado: (2015)

Antimalarial drug resistance—is it time to re-evaluate Plasmodium falciparum orthologous genes?
por: Khattak, Aamer Ali, et al.
Publicado: (2022)

High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania
por: Baraka, Vito, et al.
Publicado: (2015)

Origins and spread of novel genetic variants of sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia
por: Basuki, Sukmawati, et al.
Publicado: (2018)

Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990–2020
por: Flegg, Jennifer A., et al.
Publicado: (2022)

Multi-agent modeling and simulation of Plasmodium falciparum dynamics considering sulfadoxine-pyrimethamine resistance and environmental factors
por: Gomez, Daniela Zaffalon, et al.
Publicado: (2014)

Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V
por: Oguike, Mary C., et al.
Publicado: (2016)

Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016–2017
por: Rogier, Eric, et al.
Publicado: (2020)

The remarkable tenacity of sulfadoxine-pyrimethamine
por: Divala, Titus H, et al.
Publicado: (2019)

Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine–pyrimethamine in southern Papua, Indonesia
por: Ratcliff, A., et al.
Publicado: (2007)

Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine–pyrimethamine in Benin
por: Jafari-Guemouri, Sayeh, et al.
Publicado: (2018)

Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria
por: Olowe, Rita A, et al.
Publicado: (2023)

Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone
por: Smith, Samuel J., et al.
Publicado: (2018)

Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan
por: Khattak, Aamer A, et al.
Publicado: (2013)

Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018–2019
por: Khan, Abdul Qader, et al.
Publicado: (2020)

Molecular Markers of Sulfadoxine-Pyrimethamine Resistance in Samples from Children with Uncomplicated Plasmodium falciparum at Three Sites in Angola in 2019
por: Rosillo, Stefano R., et al.
Publicado: (2023)

Peripheral and Placental Prevalence of Sulfadoxine–Pyrimethamine Resistance Markers in Plasmodium falciparum among Pregnant Women in Southern Province, Rwanda
por: Alruwaili, Muharib, et al.
Publicado: (2023)

Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
por: Pathak, Ashish, et al.
Publicado: (2020)

Prevalence and distribution of human Plasmodium infection in Pakistan
por: Khattak, Aamer A, et al.
Publicado: (2013)

Efficacy of pyrimethamine-sulfadoxine in young children with uncomplicated falciparum malaria in rural Burkina Faso
por: Müller, Olaf, et al.
Publicado: (2004)

Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d’Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005
por: Ako, Berenger Aristide, et al.
Publicado: (2012)

Effects of Point Mutations in Plasmodium falciparum Dihydrofolate Reductase and Dihydropterate Synthase Genes on Clinical Outcomes and In Vitro Susceptibility to Sulfadoxine and Pyrimethamine
por: Bacon, David J., et al.
Publicado: (2009)

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
por: Awab, Ghulam Rahim, et al.
Publicado: (2016)

Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali
por: Mahamar, Almahamoudou, et al.
Publicado: (2022)

Distribution of Plasmodium vivaxpvdhfr and pvdhps alleles and their association with sulfadoxine–pyrimethamine treatment outcomes in Indonesia
por: Asih, Puji B. S., et al.
Publicado: (2015)

Origin and Evolution of Sulfadoxine Resistant Plasmodium falciparum
por: Vinayak, Sumiti, et al.
Publicado: (2010)

Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican Children
por: Quelhas, Diana, et al.
Publicado: (2012)

Sulfadoxine-pyrimethamine parasitological efficacy against Plasmodium falciparum among pregnant women and molecular markers of resistance in Zambia: an observational cohort study
por: Chaponda, Enesia Banda, et al.
Publicado: (2021)

A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria
por: Adegbola, Adebanjo J., et al.
Publicado: (2023)

A Study of Synergy of Combination of Eosin B with Chloroquine, Artemisinin, and Sulphadoxine-Pyrimethamine on Plasmodium falciparum In Vitro and Plasmodium berghei In Vivo
por: Sadeghi, Sedigheh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j57bi437shle831sflpa7v4c9h